Clinical trial updates
-
Alpha-thalassaemia Major
Update: 31 March 2023 No update available. Update: 20 December 2022 No update available. Update: 30 September 2022 No update available. Update: 30 June 2022 No update…
Weiterlesen » -
SLN-124
Update: 31 March 2023 Silence expects data from the ongoing phase 1 multiple dose study of SLN124 in thalassemia patients in the fourth quarter of 2023. In March 2023, the…
Weiterlesen » -
Reblozyl
‘BELIEVE’ Study in Adults with TDT β-thalassaemia Update: 31 March 2023 The Egyptian Ministry of Health and Population (MoHP), the local healthcare authorities including the Egyptian Drug Authority…
Weiterlesen » -
Gene Therapy
beti-cel Gene Therapy (betibeglogene autotemcel) – also known as ZYNTEGLO™ Update: 31 March 2023 Apheresis for first commercial ZYNTEGLO patient has been completed (09 January 2023) and an…
Weiterlesen » -
Improving Safety of Blood Transfusion
Hemanext ONE RBC Processing & Storage System Update: 31 March 2023 No update available. Update: 20 December 2022 Video on the mechanism of action of the Hemanext…
Weiterlesen »